QTREX Quantum (NASDAQ:QTEX) Shares Down 9.8% – Time to Sell?

QTREX Quantum Ltd. (NASDAQ:QTEX)’s stock price dropped 9.8% during mid-day trading on Wednesday. The stock traded as low as $1.01 and last traded at $1.01. 3,134,224 shares traded hands during mid-day trading, a decline of 62% from the average session volume of 8,220,546 shares. The stock had previously closed at $1.12.

Analyst Ratings Changes

Several brokerages have recently weighed in on QTEX. Wall Street Zen downgraded shares of QTREX Quantum from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings lowered QTREX Quantum from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, October 9th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

QTREX Quantum Price Performance

The company has a debt-to-equity ratio of 0.12, a current ratio of 2.00 and a quick ratio of 1.62. The company has a 50 day moving average price of $1.10.

QTREX Quantum (NASDAQ:QTEX) last announced its quarterly earnings data on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $0.78 million for the quarter.

Insider Transactions at QTREX Quantum

In other QTREX Quantum news, CEO Dagi Ben-Noon acquired 18,181 shares of the stock in a transaction on Friday, October 9th. The stock was acquired at an average price of $1.67 per share, for a total transaction of $30,362.27. Following the completion of the transaction, the chief executive officer directly owned 3,664,314 shares of the company’s stock, valued at $6,119,404.38. This trade represents a 0.50% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have acquired a total of 207,834 shares of company stock worth $181,275 over the last quarter. 29.40% of the stock is owned by corporate insiders.

About QTREX Quantum

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.